Picture of Cryo-Cell International logo

CCEL Cryo-Cell International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Cryo-Cell International 2025 revenue dips

Overview

Cord blood bank's fiscal 2025 revenue fell slightly from previous year

Company reported a net loss of $2.4 mln for fiscal 2025

Impairment charge of $4.4 mln recognized in Q4 due to inventory valuation changes

Outlook

Company did not provide specific financial guidance for future periods in press release

Result Drivers

IMPAIRMENT CHARGE - Co recognized a $4.4 mln impairment charge due to changes in inventory valuation

Company press release: ID:nBw61Z9m0a

Key Details

MetricBeat/MissActualConsensus Estimate
FY Revenue$31.6 mln
FY Net Income-$2.4 mln
Analyst Coverage The one available analyst rating on the shares is "hold" For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cryo-Cell International

See all news